Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.

BACKGROUND Neurofibromatosis 2 (NF2) is an autosomal dominant disease that is characterized by nervous system tumors and ocular abnormalities. OBJECTIVE To investigate genotype-phenotype correlations demonstrated for NF2-associated nervous system tumors, cataracts, and retinal lesions. METHODS Forty-eight patients with NF2 from a tertiary neurological referral center underwent screening for constitutional NF2 mutations with multiple screening methods. Each patient underwent a complete ophthalmic examination, including fluorescein angiography to detect retinal vascular lesions. RESULTS Retinal abnormalities (epiretinal membranes or retinal microaneurysms) were present in 25 of the 48 patients (52%). The occurrence of epiretinal membranes and retinal microaneurysms was highly correlated, but retinal abnormalities were not significantly correlated with cataracts (present in 39 of 47 patients [83%]). Logistic regression with full constitutional nonsense or frameshift mutations as the reference group demonstrated that somatic mosaicism was associated with a significantly lower likelihood of retinal abnormalities (odds ratio, 0.05; 95% confidence interval, 0.01-0.49). CONCLUSIONS To our knowledge, this is the first genetic, clinical, and angiographic characterization of retinal abnormalities in NF2. Severe mutations are correlated with a more severe retinal involvement. Clinical Relevance Retinal abnormalities, which can be revealed by means of fluorescein angiography, are more common in patients with NF2 who have nonsense or frameshift mutations.

[1]  C. Lázaro,et al.  The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2 , 2005, Journal of Medical Genetics.

[2]  M. Tatagiba,et al.  Screening for large mutations of the NF2 gene , 2005, Genes, chromosomes & cancer.

[3]  D. Evans,et al.  Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study. , 2004, American journal of human genetics.

[4]  D. Evans,et al.  Genotype-phenotype correlations for cataracts in neurofibromatosis 2 , 2003, Journal of medical genetics.

[5]  G. Otsuka,et al.  Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2. , 2003, Journal of neurosurgery.

[6]  L. Pizzarello Incidence of Age-Related Cataract Over a 10-Year Interval: The Beaver Dam Eye Study , 2003 .

[7]  L. Kluwe,et al.  Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas , 2003, Journal of medical genetics.

[8]  Ronald Klein,et al.  Incidence of age-related cataract over a 10-year interval: the Beaver Dam Eye Study. , 2002, Ophthalmology.

[9]  D. Evans,et al.  Predictors of the risk of mortality in neurofibromatosis 2. , 2002, American journal of human genetics.

[10]  S. Richard,et al.  Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study. , 2002, Investigative ophthalmology & visual science.

[11]  M. Kaiser-Kupfer,et al.  Loss of heterozygosity for the NF2 gene in retinal and optic nerve lesions of patients with neurofibromatosis 2 , 2002, The Journal of pathology.

[12]  C. Shields,et al.  REVIEW: COATS DISEASE: THE 2001 LUESTHER T. MERTZ LECTURE , 2002, Retina.

[13]  A. Berns,et al.  Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. , 2000, Genes & development.

[14]  L. Kluwe,et al.  Germ-line NF2 mutations and disease severity in neurofibromatosis type 2 patients with retinal abnormalities. , 1999, American journal of human genetics.

[15]  L. Kluwe,et al.  Mosaicism in sporadic neurofibromatosis 2 patients. , 1998, Human molecular genetics.

[16]  V. Mautner,et al.  The diagnosis and management of neurofibromatosis 2 in childhood. , 1998, Seminars in pediatric neurology.

[17]  M. Tatagiba,et al.  Phenotypic variability associated with 14 splice-site mutations in the NF2 gene. , 1998, American journal of medical genetics.

[18]  S. Pulst,et al.  Ocular abnormalities in neurofibromatosis 2. , 1996, American journal of ophthalmology.

[19]  M. Kaiser-Kupfer,et al.  Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. , 1996, American journal of human genetics.

[20]  R. Weksberg,et al.  Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. , 1996, American journal of human genetics.

[21]  S. Pulst,et al.  The neuroimaging and clinical spectrum of neurofibromatosis 2. , 1996, Neurosurgery.

[22]  S. Pulst,et al.  Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity and variety. , 1995, AJR. American journal of roentgenology.

[23]  G. Thomas,et al.  Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444. , 1995, Human molecular genetics.

[24]  M I Kaiser-Kupfer,et al.  Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. , 1994, American journal of medical genetics.

[25]  G. Thomas,et al.  Restriction of ocular fundus lesions to a specific subgroup of APC mutations in adenomatous polyposis coli patients , 1993, Cell.

[26]  S. Pulst,et al.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.

[27]  J. Haines,et al.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.

[28]  M. Kaiser-Kupfer,et al.  Visual impairment in patients with neurofibromatosis 2 , 1993, Neurology.

[29]  D. Evans,et al.  A clinical study of type 2 neurofibromatosis. , 1992, The Quarterly journal of medicine.

[30]  P. Mitchell,et al.  Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. , 2003, Ophthalmology (Rochester, Minn.).

[31]  A. Rothner,et al.  Retinal changes associated with neurofibromatosis 2. , 1995, Transactions of the American Ophthalmological Society.